Victory Capital Management Inc Acadia Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

A detailed history of Victory Capital Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 79,722 shares of ACAD stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,722

Previous 98,353 18.94%

Holding current value

$1.3 Million

Previous $3.08 Million 52.13%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$17.79 - $30.86 $331,445 - $574,952	-18,631 Reduced 18.94%	79,722 $1.47 Million
Q4 2023 Feb 05, 2024	SELL	$20.78 - $31.77 $25,185 - $38,505	-1,212 Reduced 1.22%	98,353 $3.08 Million
Q3 2023 Nov 06, 2023	BUY	$20.84 - $33.47 $445,850 - $716,057	21,394 Added 27.37%	99,565 $2.07 Million
Q2 2023 Jul 27, 2023	SELL	$17.8 - $25.65 $7,280 - $10,490	-409 Reduced 0.52%	78,171 $1.87 Million
Q1 2023 May 02, 2023	BUY	$16.32 - $20.92 $82,122 - $105,269	5,032 Added 6.84%	78,580 $1.48 Million

Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $2,300 - $3,018	162 Added 0.22%	73,548 $1.17 Million
Q4 2022 Feb 09, 2023	BUY	$14.2 - $18.63 $786,353 - $1.03 Million	55,377 Added 307.5%	73,386 $1.17 Million
Q3 2022 Nov 02, 2022	SELL	$14.11 - $18.27 $5,079 - $6,577	-360 Reduced 1.96%	18,009 $295,000
Q2 2022 Aug 01, 2022	BUY	$13.01 - $27.22 $2,341 - $4,899	180 Added 0.99%	18,369 $259,000
Q1 2022 May 04, 2022	SELL	$20.94 - $27.5 $5,988 - $7,865	-286 Reduced 1.55%	18,189 $335,000
Q4 2021 Feb 07, 2022	SELL	$16.79 - $27.09 $9,419 - $15,197	-561 Reduced 2.95%	18,475 $431,000
Q3 2021 Nov 02, 2021	SELL	$15.78 - $24.77 $34,179 - $53,651	-2,166 Reduced 10.22%	19,036 $316,000
Q2 2021 Aug 03, 2021	SELL	$19.4 - $27.42 $32,436 - $45,846	-1,672 Reduced 7.31%	21,202 $517,000
Q1 2021 May 04, 2021	BUY	$25.02 - $54.99 $32,576 - $71,596	1,302 Added 6.04%	22,874 $590,000
Q4 2020 Feb 01, 2021	SELL	$41.04 - $56.79 $76,416 - $105,742	-1,862 Reduced 7.95%	21,572 $1.15 Million
Q3 2020 Nov 09, 2020	BUY	$36.42 - $57.0 $26,623 - $41,667	731 Added 3.22%	23,434 $967,000
Q2 2020 Aug 07, 2020	SELL	$39.26 - $52.73 $196 - $263	-5 Reduced 0.02%	22,703 $1.1 Million
Q1 2020 May 04, 2020	BUY	$31.65 - $46.87 $633 - $937	20 Added 0.09%	22,708 $959,000
Q4 2019 Feb 06, 2020	BUY	$36.21 - $51.4 $1,774 - $2,518	49 Added 0.22%	22,688 $971,000
Q4 2019 Feb 04, 2020	BUY	$36.21 - $51.4 $124,200 - $176,302	3,430 Added 17.86%	22,639 $904,000
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $426,823 - $845,388	19,209 New	19,209 $691,000
Q3 2018 Nov 01, 2018	SELL	$13.03 - $21.81 $6,684 - $11,188	-513 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	513	513 $14,000

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Acadia Pharmaceuticals Inc Transaction History